Aimmune Therapeutics Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

Aimmune Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for potentially life-threatening food allergies. Its Characterized Oral Desensitization ImmunoTherapy (CODIT) approach desensitizes patients with defined, precise amounts of key allergens to reduce reactions from accidental exposure. The company currently has one FDA-approved medicine for peanut allergy and is pursuing additional therapies for other food allergies. Headquartered in Brisbane, California, in the San Francisco Bay Area's biotech hub, Aimmune maintains offices in Durham, North Carolina; the Paddington area of London; Dublin, Ireland; and Munich, Germany, and is part of Nestlé Health Science.

Sign up for free to view info

Company overview Employee directory